Gene Splice-Switching Technology for Treating CACNA1A-Associated Neurological Diseases
SUMMARY This technology regulates the expression of the CACNA1A gene, which encodes a neuronal calcium channel subunit, by redirecting alternative splicing to treat related neurological diseases. This approach can potentially correct gene expression variations linked to disorders including episodic ataxia, migraines, epilepsy,… Read More